Atlas Trials

PDL-1 Targeting in Resectable Oesophageal Cancer

Clinical trial NCT03087864 · COMPLETED

Trial details

NCT number
NCT03087864
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Cancer, Stage IIEsophageal Cancer Stage III
Start date
2017-06-28
Primary completion
2019-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.